On ****, Gelon Hui reported that Hainan Huluwa Pharmaceutical Group(605199.SH) recently received the drug GMP compliance inspection notice issued by the Hainan Provincial Drug Administration. This GMP compliance inspection marks the first time that the production workshops and production lines of the newly built Meian intelligent manufacturing base related to the company have passed the GMP compliance inspection. This indicates that the above-mentioned production workshops and production lines of the production base meet the requirements of drug GMP, which will be conducive to the company to continue to maintain stable product quality and production capacity to meet market demand.
葫芦娃(605199.SH)：收到药品GMP符合性检查告知书
Hainan Huluwa Pharmaceutical Group (605199.SH): Received notice of compliance inspection for pharmaceutical GMP.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.